Compromised blood–brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Angiotensin II (AngII) is a pivotal peptide implicated in the regulation of blood pressure. In addition to its systemic vascular and renal effects, AngII acts centrally to modulate the activities of neuroendocrine and sympathetic neuronal networks, influencing in turn sympatho‐humoral outflows to the circulation. Moreover, a large body of evidence supports AngII signalling dysregulation as a key mechanism contributing to exacerbated sympathoexcitation during hypertension. Due to its hydrophilic actions, circulating AngII does not cross the blood–brain barrier (BBB), signalling to the brain via the circumventricular organs which lack a tight BBB. In this review, we present and discuss recent studies from our laboratory showing that elevated circulating levels of AngII during hypertension result in disruption of the BBB integrity, allowing access of circulating AngII to critical sympathoexcitatory brain centres such as the paraventricular nucleus of the hypothalamus and the rostral ventrolateral medulla. We propose the novel hypothesis that AngII‐driven BBB breakdown constitutes a complementary mechanism by which circulating AngII, working in tandem with the central renin–angiotensin system, further exacerbates sympatho‐humoral activation during hypertension. These results are discussed within the context of a growing body of evidence in the literature supporting AngII as a pro‐inflammatory signal, and brain microglia as key cell targets mediating central AngII actions during hypertension. image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452 · cited 2×
“The BBB acts as a dynamic physical barrier at the brain–blood interface, which effectively excludes substances that are lipid insoluble, as well as those of high molecular weight (Abbott et al. 2006, 2010; Obermeier et al. 2013; Wong et al. 2013).”
BackgroundHypothalamic integration: organization of the paraventricular and supraoptic nuclei
Swanson, L. W., & Sawchenko, P. E. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.001413 · Cited by 1,991
The sympathetic control of blood pressure
Guyenet, P. G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1902 · Cited by 1,863
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 6×
“AngII-mediated generation of reactive oxygen species (ROS) within the SFO–PVN–RVLM pathway has also been implicated as an important contributor to sympathoexcitation in hypertension (Zimmerman et al. 2002,2004; Braga et al. 2011; Capone et al. 2012).”
BackgroundInfluentialThe blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662 · cited 1×
“…in neuro-inflammatory disorders and hypertension The BBB acts as a dynamic physical barrier at the brain–blood interface, which effectively excludes substances that are lipid insoluble, as well as those of high molecular weight (Abbott et al. 2006, 2010; Obermeier et al. 2013; Wong et al. 2013).”
BackgroundThe human sympathetic nervous system: its relevance in hypertension and heart failure
Parati, G., & Esler, M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs041 · Cited by 538 · cited 2×
“A large proportion of the hypertensive population is categorized as ‘neurogenic’, displaying an increased activation of the sympathetic nervous system during the initiation and maintenance phases of the disease (Parati & Esler, 2012).”
BackgroundSympathetic Activation in the Pathogenesis of Hypertension and Progression of Organ Damage
Mancia, G., Grassi, G., Giannattasio, C., & Seravalle, G. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.724 · Cited by 471 · cited 1×
“Importantly, sympathoexcitation is a major determinant of morbidity and mortality in hypertensive patients (Mancia et al. 1999; Parati & Esler, 2012).”
BackgroundBiancardi, V. C., Son, S. J., Ahmadi, S., Filosa, J. A., & Stern, J. E. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01743 · Cited by 270 · cited 7×
“in tandem to promote exacerbated sympathoexcitatory activity, contributing in turn to neurogenic hypertension (Biancardi et al. 2014).”
BackgroundMethodResultSelf-citation
Cited by
Blood-brain barrier permeability and physical exercise
Małkiewicz, M. A., Szarmach, A., Sabisz, A., Cubała, W. J., Szurowska, E., & Winklewski, P. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1403-x · Cited by 276
Brain Renin–Angiotensin System at the Intersect of Physical and Cognitive Frailty
Cosarderelioglu, C., Nidadavolu, L. S., George, C. J., Oh, E. S., Bennett, D. A., Walston, J. D., & Abadir, P. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.586314 · Cited by 134
Linking chronic kidney disease and Parkinson’s disease: a literature review
Meléndez-Flores, J. D., & Estrada-Bellmann, I. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00623-1 · Cited by 44
Metadata
- Authors
- Biancardi, V. C., & Stern, J. E.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2015-12-21
- Volume
- 594
- Issue
- 6
- Pages
- 1591-1600
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2178348782
- Cited by
- 116
- References
- 12
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.